Since they are known to be moderately sensitive to BRAF and MEK inhibitors [38], their presence at such a high rate in our population prompted us to perform a more comprehensive sequencing of “pan-negative” melanoma samples. The gene discussed is MAP2K7; the disease is melanoma.